Welcome to Novo Nordisk Science Hub
The information on this website is intended for healthcare professionals only and is provided solely for the purpose of scientific exchange. By accessing this website you accept this legal disclaimer and you expressly confirm your status as a healthcare professional.
This website is not country specific and may therefore contain information that is not applicable to your country. The website is not intended to provide medical advice and/or treatment guidance. Therefore, before prescribing any product, always refer to information approved by regulatory authorities in your country such as the prescribing information and/or the Summary of Product Characteristics. Novo Nordisk accepts no liability for the accuracy, completeness or use of information on this website, and disclaims any liability to update the information contained on this website.
Professor Vilsbøll has been involved in diabetes research since 1997, and in 2004 she established the Center for Diabetes Research at Gentofte Hospital, University of Copenhagen, Denmark now part of Steno Diabetes Center Copenhagen. Her research is focused on the pathophysiology of obesity, prediabetes, type 2 diabetes, regulation of appetite and food intake, and the utilisation of incretins as therapeutics. Integration of the gut in the understanding of human glucose metabolism has become a major focus in her lab over recent years. Professor Vilsbøll is an experienced teacher and supervises several PhD and medical students conducting diabetes research. She has more than 370 scientific publications (H-index 74), several published books and book chapters. She is a frequently invited speaker at international meetings. In addition to her teaching and research posts, Professor Vilsbøll is a member of numerous professional societies and committees, and referees for several international journals.
Athena Philis-Tsimikas
Scripps Whittier Diabetes Institute at Scripps Health, San Diego, CA, USA
Athena Philis-Tsimikas, MD is the Corporate Vice President of the Scripps Whittier Diabetes Institute at Scripps Health and the Director of Community Engagement for the Clinical Translational Science Award, housed at Scripps Research Translational Institute in San Diego, California. With over 25 years of experience, she has served as a member of the Scripps Clinic Medical Group in the Division of Endocrinology and Diabetes and leads the Diabetes Care Line for Scripps Health which creates programs, conducts research and delivers diabetes services across five Scripps hospitals, twenty five outpatient facilities and the community. She is board certified in the subspecialty of Diabetes and Endocrinology and is an Associate Clinical Professor of Medicine at UCSD’s Division of Endocrinology and Metabolism. She is a leader of the innovative Project Dulce and Dulce Digital program which cares for underserved populations with diabetes. Dr. Philis-Tsimikas and Scripps Whittier Diabetes Institute are actively promoting participation of health centers in community-based clinical research with a focus on integrating digital technologies to improve diabetes care in the ambulatory and hospital setting. Dr. Philis-Tsimikas enjoys traveling, biking and harvesting olives to make extra virgin olive oil in Greece
Read full bio
Stephen Bain
Swansea University, Swansea, UK
Stephen Bain is the Clinical Director of the Diabetes Research Unit, Swansea University and Medical Director for Research & Development for Swansea Bay University Health Board.
Professor Bain completed his undergraduate training at St John's College, Cambridge, and then was clinically trained at King's College Hospital, London. On qualifying in 1983, he went on to hold junior appointments in London, the East Midlands, and the West Midlands, UK. His research centred on the genetics of type 1 diabetes, and he was granted a Medical Research Council Lectureship. He became a Fellow of the Royal College of Physicians UK in 1996 and was appointed to a newly created Chair in Medicine (Diabetes) in the University of Wales Swansea in 2005. His clinical interests include the genetics of diabetic nephropathy, new therapies for diabetes and the provision of diabetes services within the community. He has been Chief Investigator for several multi-centre trials investigating novel therapies for diabetes.
Professor Bain is the Diabetes Lead Clinician for the Swansea Bay University Health Board and chairs the Joint Clinical Research Facility in Swansea. He is currently Chair of the National Specialist Advisory Group (NSAG) for Diabetes in Wales.
Read full bio